Pasithea Therapeutics Corp.
KTTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,923 | $16,331 | $33,088 | $52,967 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $41 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $446 | $321 | $989 | $334 |
| Total Curr. Assets | $7,368 | $16,692 | $34,077 | $53,300 |
| Property Plant & Equip (Net) | $122 | $220 | $626 | $20 |
| Goodwill | $1,263 | $1,263 | $1,263 | $0 |
| Intangibles | $7,311 | $7,941 | $8,571 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $643 | $0 |
| Total NC Assets | $8,696 | $9,425 | $11,103 | $20 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $16,065 | $26,117 | $45,180 | $53,321 |
| Liabilities | – | – | – | – |
| Payables | $1,120 | $0 | $1,481 | $0 |
| Short-Term Debt | $0 | $82 | $160 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $2,552 | $236 | $447 |
| Total Curr. Liab. | $1,120 | $2,634 | $1,878 | $447 |
| LT Debt | $0 | $0 | $344 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $162 | $84 | $460 | $1,453 |
| Total NC Liab. | $162 | $84 | $804 | $1,453 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $82 | $504 | $0 |
| Total Liabilities | $1,282 | $2,718 | $2,682 | $1,900 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $18 |
| Retained Earnings | -$49,583 | -$35,319 | -$19,357 | -$2,215 |
| AOCI | -$7 | -$5 | -$1 | -$11 |
| Other Equity | $64,372 | $58,722 | $61,856 | $53,628 |
| Total Equity | $14,783 | $23,398 | $42,498 | $51,421 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $16,065 | $26,117 | $45,180 | $53,321 |
| Net Debt | -$6,923 | -$16,249 | -$32,583 | -$52,967 |